U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07379372) titled 'Bladder Overactivity and Post-Botulinum Toxin Telemonitoring' on Dec. 19, 2025.
Brief Summary: Prospective, randomized, controlled, single-center study to compare the feasibility of home monitoring for patients receiving intradetrusor botulinum toxin injections with that of the usual hospital-based follow-up.
Study Start Date: March 02
Study Type: INTERVENTIONAL
Condition:
Overactive Bladder
Intervention:
OTHER: home care
6-week follow-up visit: At home (The service provider will bring the necessary equipment for the various measurements and the questionnaires, and will explain their use to the patient. The provider will retu...